492 related articles for article (PubMed ID: 18930603)
1. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.
Magura S; Lee JD; Hershberger J; Joseph H; Marsch L; Shropshire C; Rosenblum A
Drug Alcohol Depend; 2009 Jan; 99(1-3):222-30. PubMed ID: 18930603
[TBL] [Abstract][Full Text] [Related]
2. Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance.
Awgu E; Magura S; Rosenblum A
J Psychoactive Drugs; 2010 Sep; 42(3):339-46. PubMed ID: 21053756
[TBL] [Abstract][Full Text] [Related]
3. [Buprenorphine or methadone for detoxification of young opioid addicts?].
Ebner R; Schreiber W; Zierer C
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
[TBL] [Abstract][Full Text] [Related]
4. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
[TBL] [Abstract][Full Text] [Related]
5. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
[TBL] [Abstract][Full Text] [Related]
6. Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial.
Lee JD; McDonald R; Grossman E; McNeely J; Laska E; Rotrosen J; Gourevitch MN
Addiction; 2015 Jun; 110(6):1008-14. PubMed ID: 25703440
[TBL] [Abstract][Full Text] [Related]
7. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
[TBL] [Abstract][Full Text] [Related]
8. Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort.
Harris A; Selling D; Luther C; Hershberger J; Brittain J; Dickman S; Glick A; Lee JD
Subst Abus; 2012; 33(1):70-5. PubMed ID: 22263715
[TBL] [Abstract][Full Text] [Related]
9. Buprenorphine for heroin addicts: the issue of illicit opioid abuse during maintenance.
Cho E; Dermatis H; Galanter M
Subst Abus; 2006 Jun; 27(1-2):1-3. PubMed ID: 17062539
[No Abstract] [Full Text] [Related]
10. Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17.
Lim S; Cherian T; Katyal M; Goldfeld KS; McDonald R; Wiewel E; Khan M; Krawczyk N; Braunstein S; Murphy SM; Jalali A; Jeng PJ; MacDonald R; Lee JD
Addiction; 2023 Mar; 118(3):459-467. PubMed ID: 36305669
[TBL] [Abstract][Full Text] [Related]
11. A controlled trial of buprenorphine treatment for opioid dependence.
Johnson RE; Jaffe JH; Fudala PJ
JAMA; 1992 May; 267(20):2750-5. PubMed ID: 1578593
[TBL] [Abstract][Full Text] [Related]
12. A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
Fingerhood MI; King VL; Brooner RK; Rastegar DA
Subst Abus; 2014; 35(2):122-6. PubMed ID: 24821346
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
Ling W; Wesson DR; Charuvastra C; Klett CJ
Arch Gen Psychiatry; 1996 May; 53(5):401-7. PubMed ID: 8624183
[TBL] [Abstract][Full Text] [Related]
14. Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration.
Cherian T; Lim S; Katyal M; Goldfeld KS; McDonald R; Wiewel E; Khan M; Krawczyk N; Braunstein S; Murphy SM; Jalali A; Jeng PJ; Rosner Z; MacDonald R; Lee JD
Drug Alcohol Depend; 2024 Jun; 259():111274. PubMed ID: 38643529
[TBL] [Abstract][Full Text] [Related]
15. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Kakko J; Heilig M; Sarman I
Drug Alcohol Depend; 2008 Jul; 96(1-2):69-78. PubMed ID: 18355989
[TBL] [Abstract][Full Text] [Related]
17. Exposure to opioid maintenance treatment reduces long-term mortality.
Gibson A; Degenhardt L; Mattick RP; Ali R; White J; O'Brien S
Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
[TBL] [Abstract][Full Text] [Related]
18. Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
Stallvik M; Nordstrand B; Kristensen Ø; Bathen J; Skogvoll E; Spigset O
Drug Alcohol Depend; 2013 Apr; 129(1-2):88-93. PubMed ID: 23084592
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.
Gordon MS; Kinlock TW; Schwartz RP; O'Grady KE; Fitzgerald TT; Vocci FJ
Drug Alcohol Depend; 2017 Mar; 172():34-42. PubMed ID: 28107680
[TBL] [Abstract][Full Text] [Related]
20. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
Marzo JN; Rotily M; Meroueh F; Varastet M; Hunault C; Obradovic I; Zin A
Addiction; 2009 Jul; 104(7):1233-40. PubMed ID: 19426291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
